The Technical Analyst
cbdMD Inc [YCBD]
Exchange: AMEX Industry: Drug Manufacturers General Specialty & Generic
cbdMD Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-8.79% $0.676
America/New_York / 10 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.06 mill |
| EPS: | -10.29 |
| P/E: | -0.0700 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 3.05 mill |
| Avg Daily Volume: | 0.335 mill |
| RATING 2024-05-10 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0700 | sector: PE 12.30 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.0700 | industry: PE -13.90 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.547 - 0.805 ( +/- 19.09%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-29 | Whitford Bradley Nelson | Sell | 0 | Common Stock |
| 2022-01-27 | Whitford Bradley Nelson | Sell | 334 | Stock Options (Right to Buy) |
| 2023-01-09 | Whitford Bradley Nelson | Sell | 334 | Stock Options (Right to Buy) |
| 2024-03-29 | Swift Sibyl Nichole | Buy | 4 000 | Common Stock |
| 2024-03-29 | Swift Sibyl Nichole | Buy | 2 000 | Stock Options (Right to Buy) |
| INSIDER POWER |
|---|
| 93.38 |
| Last 98 transactions |
| Buy: 7 173 287 | Sell: 4 440 585 |
Forecast:
16:00 - $0.676
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.676
Forecast 2: 16:00 - $0.676
Forecast 3: 16:00 - $0.676
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.676 (-8.79% ) |
| Volume | 0.175 mill |
| Avg. Vol. | 0.335 mill |
| % of Avg. Vol | 52.18 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For YCBD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
YCBD
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
Last 10 Buy Signals
Latest Press Releases
2024-02-13 16:10:00 - Press Release
Cbdmd Reduces Year Over Year Net Loss From Operations By $3.0 Million
Cbdmd leads with strategic improvements and is building momentum with atrx line charlotte, north carolina--(newsfile corp. - february 13, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa), one of the nation's leading and most highly trusted and recognized cbd companies, and operator of the leading cbd brands - its flagship brand cbdmd, its animal health brand paw cbd, today announced our financial results for our first quarter of fiscal 2024 ending december 31, 2023. for the first quarter of fiscal 2024, we continued to make strong year over year progress on our turnaround.
2024-02-08 16:05:00 - Press Release
Cbdmd, Inc. To Host Conference Call To Discuss First Quarter Of Fiscal 2024 Results
Charlotte, north carolina--(newsfile corp. - february 8, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa), one of the nation's leading, highly trusted and widely recognized cbd companies, today announces that it will host a conference call at 4:20 p.m., eastern time, on tuesday, february 13, 2024, to discuss the company's december 31, 2023 first quarter of fiscal 2024 financial results and business progress.
2024-02-08 10:10:00 - Press Release
Cbdmd Welcomes Vice President Of Wholesale Sales, Joe Baghadjian- Paving The Way For Future Growth
Charlotte, north carolina--(newsfile corp. - february 8, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), one of the nation's leading and most trusted cbd companies, proudly announces the appointment of joe baghadjian as vice president of wholesale sales. the addition of joe baghadjian to the cbdmd team brings a wealth of expertise and a unique skill set to the cbdmd.
2024-02-02 17:00:00 - Press Release
Cbdmd Announces Financing Of $1,250,000
Charlotte, north carolina--(newsfile corp. - february 2, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), a premier provider of high-quality cbd products and functional mushroom supplements under atrx labs today announced that it has entered into a securities purchase agreement (the "spa") with five institutional investors (the "investors") whereby the investors advanced the company an aggregate of $1,250,000 gross proceeds and the company issued each investor a senior secured original issue discount convertible promissory note (collectively, the "notes") in the aggregate principal amount of $1,541,666. the company intends to use the proceeds from the issuance of the notes for working capital general corporate purposes.
2024-01-31 10:56:00 - Press Release
Cbdmd Unveils Thcv+cbg Energy Softgels, Ushering In A New Era Of Wellness Solutions
Charlotte, north carolina--(newsfile corp. - january 31, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), a premier provider of high-quality cbd products, proudly unveils its latest innovation: thcv+cbg energy softgels. this product integrates the potency of two dynamic cannabinoids, thcv and cbg, along with 50 mg of caffeine and 500 mcg of b12, creating a unique formula designed to enhance energy, focus, and clarity – an ideal solution for modern, fast-paced lives.
Latest News
2024-02-08 16:05:00 - Newsfile Corp
cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - February 8, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 13, 2024, to discuss the company's December 31, 2023 first quarter of fiscal 2024 financial results and business progress.
2023-12-20 12:47:00 - Newsfile Corp
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - December 20, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Friday December 22, 2023, to discuss the company's September 30, 2023 fourth quarter of fiscal 2023 and full year of fiscal 2023 financial results and business progress.
2023-08-07 10:00:00 - Newsfile Corp
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday August 10, 2023, to discuss the company's June 30, 2023 third quarter of fiscal 2023 financial results and business progress.
2023-05-15 19:30:10 - Seeking Alpha
cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q2 2023 Earnings Conference Call May 15, 2023 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Sibyl Swift - Chief Science Officer & VP Regulatory Affairs Conference Call Participants Anthony Vendetti - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. March 31, 2023, Second Quarter of Fiscal '23 Earnings Call and Update.
2023-05-10 14:59:00 - Newsfile Corp
cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress.
2023-02-13 19:37:05 - Seeking Alpha
cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q4 2022 Earnings Conference Call February 13, 2022 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - CFO and COO Kevin MacDermott - President Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s December 31, 2022 First Quarter of Fiscal 2023 Earnings Call and Update.
2022-12-16 14:02:05 - Seeking Alpha
cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q4 2022 Earnings Conference Call December 15, 2022 4:15 PM ET Company Participants Ronan Kennedy - CFO and COO Kevin MacDermott - President Sibyl Swift - VP of Scientific and Regulatory Affairs Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s September 30 Fourth Quarter and Fiscal 2022 Earnings Call and Update.
2022-12-14 17:06:00 - Newsfile Corp
cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results
Charlotte, North Carolina--(Newsfile Corp. - December 14, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 15, 2022, to discuss the company's September 30, 2022 fourth quarter and fiscal 2022 financial results and business progress.CONFERENCE CALL DETAILSThursday, December 15, 2022, 4:15 p.m. Eastern Time
2022-08-13 16:14:08 - Seeking Alpha
cbdMD, Inc. (YCBD) Q3 2022 Results - Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q3 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Scott Stephen - Chairman Kevin MacDermott - President Dr. Sibyl Swift - Vice President of Scientific and Regulatory Affairs Conference Call Participants Jeff Porter - Porter Capital Management Operator Good afternoon. Welcome to the cbdMD Inc.'s June 30, 2022 Third Quarter of Fiscal 2022 Earnings Call and Update.
2022-05-17 19:22:01 - Seeking Alpha
cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q2 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Marty Sumichrast - Chairman and Co-CEO Sibyl Swift - VP, Scientific & Regulatory Affairs Conference Call Participants Operator Good afternoon, and welcome to cbdMD, Inc.'s March 31, 2022, Second Quarter of Fiscal 2022 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its second quarter of fiscal year 2022 results, which followed the filing of its quarterly report on Form 10-Q.